Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_assertion type Assertion NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_head.
- NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_assertion description "[Altogether, these data provide evidence that the repression of syndecan-2 by Wnt/?-catenin/TCF signaling contributes to the resistance of osteosarcoma cells to doxorubicin and suggest that TCF inhibition may represent a novel therapeutic strategy in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_provenance.
- NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_assertion evidence source_evidence_literature NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_provenance.
- NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_assertion SIO_000772 22550000 NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_provenance.
- NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_assertion wasDerivedFrom befree-20140225 NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_provenance.
- NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_assertion wasGeneratedBy ECO_0000203 NP306577.RATqnPseKCcz17ZBNG-gB6CKNHSnH6GfeotxXK5JilY7M130_provenance.